GlassScriptPhysician profile
Gregory Lucien Simpson
NPI 1740488238
$809.61
in general payments reported to CMS, 2019-2025
13 companies · $96.10 in 2025
The $96.10 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $29.06 · 2021: $67.39 · 2022: $86.24 · 2023: $189 · 2024: $105 · 2025: $96.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $135.83 | 2019-2022 | |
| Amgen INC. | $119.19 | 2023-2025 | Otezla |
| Neotract INC. | $109.12 | 2019 | |
| Pfizer INC. | $108.46 | 2023 | |
| Medtronic, INC. | $95.43 | 2021-2022 | |
| Organogenesis INC. | $53.61 | 2023 | Puraply |
| Laborie Medical Technologies Corp. | $46.00 | 2025 | Aquarius Lt |
| Astellas Pharma US INC | $43.38 | 2020-2021 | |
| Janssen Biotech, INC. | $35.33 | 2019-2022 | |
| Abbott Laboratories | $26.63 | 2024 | Proclaim |
| Dermavant Sciences, INC. | $21.64 | 2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $14.99 | 2025 | Zoryve |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.